This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ZirMed Launches Clinical Link

LOUISVILLE, Ky., Feb. 4, 2013 /PRNewswire/ --  ZirMed, Inc. announces the release of a secure, national information exchange for healthcare providers.  The innovative solution, called ZirMed Clinical Link™ harnesses the power of ZirMed's connected network of healthcare providers facilitating secure provider-to-provider communications from any EMR or information management system via ZirMed's software-as-a-service (SaaS) platform.

"Unlocking and sharing patient information across the provider continuum is critical for healthcare providers to gain meaningful cost savings and promised patient care benefits," said ZirMed CEO Tom Butts.  "The challenge is despite the HITECH and Meaningful Use incentives and adoption of EMR technologies, the information remains locked away in silos.  ZirMed builds upon a platform of knowledge in securely moving patient information and the connectivity of over one hundred thousand healthcare providers from virtually every setting of care.  With the power of our platform and scope of our delivery, the release of this solution will be immediately available to tens of thousands of healthcare businesses."

ZirMed Clinical Link™ is HIPAA compliant provider-to-provider communication platform is immediately available to all ZirMed clients day one.  The system was designed with the workflow and practice patterns of healthcare providers at top of mind by enabling authenticated users to invite their referral network to join the secure network and easily exchange information. Clinical Link enables providers to communicate directly with one another via secure messaging functionality, as well as transfer administrative and vital clinical information via structured or unstructured data as attachments.  Clinical Link is not merely a secure email system.  ZirMed worked with hundreds of providers to design a workflow automation system that enables providers to eliminate phone, fax, and mail used today for referrals and patient transition of care, and can avoid HIPAA compliance issues associated with standard email and dated processes.

"The difference between ZirMed Clinical Link™ and legacy processes is night and day," said Bethany Williams, VP of Product Marketing.  "The speed and availability of information makes clinical and administrative decisions fast - actions happen in minutes, not days.  There are no more questions around mailing a chart or faxing the paperwork.  With Clinical Link, the provider merely points, clicks and sends."

ZirMed Clinical Link™ is built upon the ZirMed Link™ Platform.  Unlike Health Information Exchanges, providers can easily transition patients and clinical documents between care settings without having the complex implementation of expensive and cumbersome architecture and point-to-point interfaces.  Rather than rely on installed software and point-to-point integrations, ZirMed Clinical Link™ is a fully web-based solution, which is system agnostic and doesn't require major technical integrations.  Clinical Link's framework is based off a social network approach that reaches a broader base of providers regardless of their IT budget, infrastructure, and technologies in place.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs